News
Latest news from CHV and our portfolio companies
Featured News
EyeCool Therapeutics, Inc. is looking forward to participating in BTIG’s 5th Annual Ophthalmology Day on Monday, December 1, 2025 from 2:30-2:55 PM ET, where leaders across the field will explore emerging innovation in ophthalmology. Our…
Insights & Impacts: The latest from CHV
Sera Prognostics, Inc., The Pregnancy Company® (“Sera” or the “Company”) (Nasdaq: SERA), which focuses on
Epitel, Inc., a leader in AI technologies for patient-focused brain health solutions, is pleased to
Sera Prognostics, Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
Study will assess the Company’s Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial
Funding Will Support Clinical Studies of the VelocityTM pAVF System in Patients with Chronic Kidney
PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company redefining cancer treatment with therapeutics
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
Innovative Leader in AI-Powered Brain Health Solutions Strengthens Board with Accomplished Remote Patient Monitoring Executive
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads